1932

Abstract

This review provides an overview of the relationship between depression and cognition in the elderly, with an emphasis on psychotherapies and nonpharmacologic approaches. We first review the clinical presentation of late-life depression and comorbid cognitive impairment, as well as the epidemiology and risk factors for cognitive impairment in late-life depression and the temporal relationship between depression and cognitive impairment. Next, we discuss the salient topic of elderly suicide and cognitive impairment. We then touch briefly on the neuropsychological deficits, biomarkers, and neuroimaging findings in late-life depression with comorbid cognitive impairment. We then focus most of this review on psychotherapies and nontraditional treatments for late-life depression with comorbid cognitive impairment and examine what evidence, if any, exists of the cognitive and functional benefits of these treatments. Finally, we examine the cognitive effects of pharmacologic treatments and brain stimulation therapies.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-clinpsy-032814-112828
2015-03-28
2024-06-19
Loading full text...

Full text loading...

/deliver/fulltext/clinpsy/11/1/annurev-clinpsy-032814-112828.html?itemId=/content/journals/10.1146/annurev-clinpsy-032814-112828&mimeType=html&fmt=ahah

Literature Cited

  1. Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H. et al. 2010. Depression and cognitive function in maintenance hemodialysis patients. Am. J. Kidney Dis. 56:704–12 [Google Scholar]
  2. Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM. 2012. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia. J. Neurol. 259:83–92 [Google Scholar]
  3. Alexopoulos GS, Hoptman MJ, Kanellopoulos D, Murphy CF, Lim KO, Gunning FM. 2012. Functional connectivity in the cognitive control network and the default mode network in late-life depression. J. Affect. Disord. 139:56–65 [Google Scholar]
  4. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D. et al. 2008. Microstructural white matter abnormalities and remission of geriatric depression. Am. J. Psychiatry 165:238–44 [Google Scholar]
  5. Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D. et al. 2011. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch. Gen. Psychiatry 68:33–41 [Google Scholar]
  6. Am. Found. Suicide Prev 2012. Facts and Figures. New York: Am. Found. Suicide Prev https://www.afsp.org/understanding-suicide/facts-and-figures [Google Scholar]
  7. Am. Psychiatr. Assoc 2013. Diagnostic and Statistical Manual of Mental Disorders. Arlington, VA: Am. Psychiatr. Publ, 5th ed.. [Google Scholar]
  8. Anderson-Hanley C, Arciero PJ, Brickman AM, Nimon JP, Okuma N. et al. 2012. Exergaming and older adult cognition: a cluster randomized clinical trial. Am. J. Prev. Med. 42:109–19 [Google Scholar]
  9. Apostolova LG, Di LJ, Duffy EL, Brook J, Elashoff D. et al. 2014. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 37:315–26 [Google Scholar]
  10. Areán P, Hegel M, Vannoy S, Fan MY, Unuzter J. 2008. Effectiveness of problem-solving therapy for older, primary care patients with depression: results from the IMPACT project. Gerontologist 48:311–23 [Google Scholar]
  11. Areán PA, Raue P, Mackin RS, Kanellopoulos D, McCulloch C. et al. 2010. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Am. J. Psychiatry 167:1391–98 [Google Scholar]
  12. Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA. et al. 2012. Plasma biomarkers of depressive symptoms in older adults. Transl. Psychiatry 3:2e65 [Google Scholar]
  13. Baba K, Baba H, Noguchi I, Arai R, Suzuki T. et al. 2010. Executive dysfunction in remitted late-life depression: Juntendo University Mood Disorder Projects (JUMP). J. Neuropsychiatry Clin. Neurosci. 22:70–74 [Google Scholar]
  14. Barch DM, D'Angelo G, Pieper C, Wilkins CH, Welsh-Bohmer K. et al. 2012. Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. Am. J. Geriatr. Psychiatry 20:682–90 [Google Scholar]
  15. Bhalla RK, Butters MA, Becker JT, Houck PR, Snitz BE. et al. 2009. Patterns of mild cognitive impairment after treatment of depression in the elderly. Am. J. Geriatr. Psychiatry 17:308–16 [Google Scholar]
  16. Blank K. 2009. Older adults & substance use: new data highlight concerns. SAMHSA News Jan–Feb. http://www.samhsa.gov/ [Google Scholar]
  17. Blasko I, Kemmler G, Jungwirth S, Wichart I, Krampla W. et al. 2010. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease. Am. J. Geriatr. Psychiatry 18:973–82 [Google Scholar]
  18. Blazer D. 2003. Depression in late life: review and commentary. J. Gerontol. A Biol. Sci. Med. Sci. 58:3249–65 [Google Scholar]
  19. Bogner HR, Bruce ML, Reynolds CF 3rd, Mulsant BH, Cary MS. et al. 2007. The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT study. Int. J. Geriatr. Psychiatry 22:922–29 [Google Scholar]
  20. Bogner HR, Richie MB, de Vries HF, Morales KH. 2009. Depression, cognition, and apolipoprotein E genotype: latent class approach to identifying subtype. Am. Geriatr. Psychiatry 17:344–52 [Google Scholar]
  21. Bratek A, Zawada K, Beil-Gawełczyk J, Beil S, Sozańska E. et al. 2014. Depressiveness, symptoms of anxiety and cognitive dysfunctions in patients with asthma and chronic obstructive pulmonary disease (COPD): possible associations with inflammation markers: a pilot study. J. Neural. Transm. In press. doi: 10.1007/s00702-014-1171-9 [Google Scholar]
  22. Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK. et al. 2008. Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis. Assoc. Disord. 22:261–68 [Google Scholar]
  23. Byers AL, Yaffe K. 2011. Depression and risk of developing dementia. Nat. Rev. Neurol. 7:323–31 [Google Scholar]
  24. Campbell GB, Whyte EM, Sereika SM, Dew MA, Reynolds CF. et al. 2014. Reliability and validity of the executive interview (EXIT) and quick EXIT among community dwelling older adults. Am. J. Geriatr. Psychiatry 221444–51 [Google Scholar]
  25. Carreira K, Miller MD, Frank E, Houck PR, Morse JQ. et al. 2008. A controlled evaluation of monthly maintenance interpersonal psychotherapy in late-life depression with varying levels of cognitive function. Int. J. Geriatr. Psychiatry 23:1110–13 [Google Scholar]
  26. Ceramidas DM. 2012. Faith-based cognitive behavioral therapy: easing depression in the elderly with cognitive decline. J. Christ. Nurs. 29:42–48 [Google Scholar]
  27. Chan SS, Lyness JM, Conwell Y. 2007. Do cerebrovascular risk factors confer risk for suicide in later life? A case-control study. Am. J. Geriatr. Psychiatry 15:541–44 [Google Scholar]
  28. Choi NG, Hegel MT, Marti CN, Marinucci ML, Sirrianni L. et al. 2014. Telehealth problem-solving therapy for depressed low-income homebound older adults. Am. J. Geriatr. Psychiatry 22:3263–71 [Google Scholar]
  29. Conwell Y, Van Orden K, Caine ED. 2011. Suicide in older adults. Psychiatr. Clin. N. Am. 34:451–68 [Google Scholar]
  30. Cross K, Flores R, Butterfield J, Blackman M, Lee S. 2012. The effect of passive listening versus active observation of music and dance performances on memory recognition and mild to moderate depression in cognitively impaired older adults. Psychol. Rep. 111:413–23 [Google Scholar]
  31. Dear BF, Zou J, Titov N, Lorian C, Johnston L. et al. 2013. Internet-delivered cognitive behavioural therapy for depression: a feasibility open trial for older adults. Aust. N. Z. J. Psychiatry 47:169–76 [Google Scholar]
  32. Denburg NL, Cole CA, Hernandez M, Yamada TH, Tranel D. et al. 2007. The orbitofrontal cortex, real-world decision making, and normal aging. Ann. N. Y. Acad. Sci. 1121:480–98 [Google Scholar]
  33. Devi G, Voss HU, Levine D, Abrassart D, Heier L. et al. 2014. Open-label, short-term, repetitive transcranial magnetic stimulation in patients with Alzheimer's disease with functional imaging correlates and literature review. Am. J. Alzheimers Dis. Other Dement. 29:3248–55 [Google Scholar]
  34. Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Gattaz WF. et al. 2013. Reduced serum nerve growth factor in patients with late-life depression. Am. J. Geriatr. Psychiatry 21:493–96 [Google Scholar]
  35. Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF. et al. 2012. Circulating glial-derived neurotrophic factor is reduced in late-life depression. J. Psychiatr. Res. 46:135–39 [Google Scholar]
  36. Dombrovski AY, Szanto K, Clark L, Reynolds CF, Siegle GJ. 2013. Reward signals, attempted suicide, and impulsivity in late-life depression. JAMA Psychiatry 70:101020–30 [Google Scholar]
  37. Dombrovski AY, Szanto K, Siegle GJ, Wallace ML, Forman SD. et al. 2011. Lethal forethought: delayed reward discounting differentiates high- and low-lethality suicide attempts in old age. Biol. Psychiatry 70:138–44 [Google Scholar]
  38. Donker T, Batterham PJ, Warmerdam L, Bennett K, Bennett A. et al. 2013a. Predictors and moderators of response to internet-delivered interpersonal psychotherapy and cognitive behavior therapy for depression. J. Affect. Disord. 151:343–51 [Google Scholar]
  39. Donker T, Petrie K, Proudfoot J, Clarke J, Birch M. et al. 2013b. Smartphones for smarter delivery of mental health programs: a systematic review. J. Med. Internet Res. 15:e247 [Google Scholar]
  40. Doyle T, Palmer S, Johnson J, Babyak MA, Smith P. et al. 2013. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int. J. Psychiatry Med. 45:189–202 [Google Scholar]
  41. Dubois B, Litvan I. 2000. The FAB: a frontal assessment battery at bedside. Neurology 55:1621–26 [Google Scholar]
  42. Eden J, Le M, Maslow K, Blazer D. 2012. The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands? Washington, DC: Natl. Acad. Press [Google Scholar]
  43. Elias MF, Dore GA, Davey A. 2013. Kidney disease and cognitive function. Contrib. Nephrol. 179:42–57 [Google Scholar]
  44. Erickson KI, Gildengers AG, Butters MA. 2013. Physical activity and brain plasticity in late adulthood. Dialogues Clin. Neurosci. 15:99–108 [Google Scholar]
  45. Erickson KI, Miller DL, Roecklein KA. 2012. The aging hippocampus: interactions between exercise, depression, and BDNF. Neuroscientist 18:82–97 [Google Scholar]
  46. Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM. et al. 2012. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch. Gen. Psychiatry 69:244–55 [Google Scholar]
  47. Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A. et al. 2012. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: High IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl. Psychiatry 2:e88 [Google Scholar]
  48. Gard T, Hölzel BK, Lazar SW. 2014. The potential effects of meditation on age-related cognitive decline: a systematic review. Ann. N. Y. Acad. Sci. 1307:89–103 [Google Scholar]
  49. Hariprasad VR, Varambally S, Varambally PT, Thirthalli J, Basavaraddi IV. et al. 2013. Designing, validation and feasibility of a yoga-based intervention for elderly. Indian J. Psychiatry 55:S344–49 [Google Scholar]
  50. Hars M, Herrmann FR, Gold G, Rizzoli R, Trombetti A. 2014. Effect of music-based multitask training on cognition and mood in older adults. Age Ageing 43:196–200 [Google Scholar]
  51. Holtzheimer PE, Meeks TW, Kelley ME, Mufti M, Young R. et al. 2008. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. Int. J. Geriatr. Psychiatry 23:625–31 [Google Scholar]
  52. Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW. et al. 2008. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch. Gen. Psychiatry 65:906–12 [Google Scholar]
  53. Joosten-Weyn Banningh LW, Kessels RP, Olde Rikkert MG, Geleijns-Lanting CE, Kraaimaat FW. 2008. A cognitive behavioural group therapy for patients diagnosed with mild cognitive impairment and their significant others: feasibility and preliminary results. Clin. Rehabil. 22:731–40 [Google Scholar]
  54. Katona C, Hansen T, Olsen CK. 2012. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int. Clin. Psychopharmacol. 27:215–23 [Google Scholar]
  55. Katza R, De Sanctisa P, Mahoneya JR, Sehatpoura P, Murphy CF. et al. 2010. Cognitive control in late-life depression: response inhibition deficits and dysfunction of the anterior cingulate cortex. Am. J. Geriatr. Psychiatry 18:1017–25 [Google Scholar]
  56. Keefe RS, McClintock SM, Roth RM, Doraiswamy PM, Tiger S. et al. 2014. Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J. Clin. Psych. 75:8864–76 [Google Scholar]
  57. Khawam EA, Laurencic G, Malone DA. 2006. Side effects of antidepressants: an overview. Clevel. Clin. J. Med. 73:351–53356–61 [Google Scholar]
  58. Kiosses DN, Areán PA, Teri L, Alexopoulos GS. 2010. Home-delivered problem adaptation therapy (PATH) for depressed, cognitively impaired, disabled elders: a preliminary study. Am. J. Geriatr. Psychiatry 18:988–98 [Google Scholar]
  59. Koenig AM, Bhalla RK, Meryl AB. 2014. Cognitive functioning and late-life depression. J. Int. Neuropsychol. Soc. 20:1–7 [Google Scholar]
  60. Köhler S, Ashton CH, Marsh R, Thomas AJ, Barnett NA, O'Brien JT. 2011. Electrophysiological changes in late life depression and their relation to structural brain changes. Int. Psychogeriatr. 23:141–48 [Google Scholar]
  61. Köhler S, Thomas AJ, Lloyd A, Barber R, Almeida OP. et al. 2010a. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br. J. Psychiatry 196:143–49 [Google Scholar]
  62. Köhler S, van Boxtel MP, van Os J, Thomas AJ, O'Brien JT. et al. 2010b. Depressive symptoms and cognitive decline in community-dwelling older adults. J. Am. Geriatr. Soc. 58:873–79 [Google Scholar]
  63. Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE. 2003. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 28:2045–48 [Google Scholar]
  64. Kowal P, Kahn K, Ng N, Naidoo N, Abdullah S. et al. 2010. Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration. Glob. Health Action S2:11–22 [Google Scholar]
  65. Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME. et al. 2004. Clinical characteristics of magnetic resonance imaging–defined subcortical ischemic depression. Biol. Psychiatry 55:390–97 [Google Scholar]
  66. Kumar A, Kepe V, Barrio JR, Siddarth P, Manoukian V. et al. 2011. Protein binding in patients with late-life depression. Arch. Gen. Psychiatry 68:1143–50 [Google Scholar]
  67. Kurella M, Kimmel PL, Young BS, Chertow GM. 2005. Suicide in the United States end-stage renal disease program. J. Am. Soc. Nephrol. 16:774–81 [Google Scholar]
  68. Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M. et al. 2011. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am. J. Geriatr. Psychiatry 19:839–50 [Google Scholar]
  69. Lavretsky H, Siddarth P, Kepe V, Ercoli LM, Miller KJ. et al. 2009. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Am. J. Geriatr. Psychiatry 17:493–502 [Google Scholar]
  70. Lee GJ, Lu PH, Hua X, Lee S, Wu S. et al. 2012. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol. Psychiatry 71:814–21 [Google Scholar]
  71. Lenze EJ, Sheffrin M, Driscoll HC, Mulsant BH, Pollock BG. et al. 2008. Incomplete response in late-life depression: getting to remission. Dialogues Clin. Neurosci. 10:419–30 [Google Scholar]
  72. Lenze EJ, Skidmore ER, Begley AE, Newcomer JW, Butters MA. et al. 2012. Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study. Int. J. Geriatr. Psychiatry 27:974–80 [Google Scholar]
  73. Lisanby SH. 2007. Electroconvulsive therapy for depression. New Engl. J. Med. 357:1939–45 [Google Scholar]
  74. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC. et al. 2009. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 72:2115–21 [Google Scholar]
  75. Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N. et al. 2013. The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. Am. J. Geriatr. Psychiatry 21:906–14 [Google Scholar]
  76. Mackin RS, Nelson JC, Delucchi K, Raue P, Byers A. et al. 2014a. Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction. Am. J. Geriatr. Psychiatry 221496–503 [Google Scholar]
  77. Mackin RS, Nelson JC, Delucchi KL, Raue PJ, Satre DD. et al. 2014b. Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction. Am. J. Geriatr. Psychiatry 221633–41 [Google Scholar]
  78. Madsen K, Hasselbalch BJ, Frederiksen KS, Haahr ME, Gade A. et al. 2012. Lack of association between prior depressive episodes and cerebral [11C]PiB binding. Neurobiol. Aging 33:2334–42 [Google Scholar]
  79. Manning KJ, Alexopoulos GS, Banerjee S, Shizuko Morimoto S, Seirup JK. et al. 2013. Executive functioning complaints and escitalopram treatment response in late-life depression. Am. J. Geriatr. Psychiatry. In press. http://dx.doi.org/10.1016/j.jagp.2013.11.005 [Google Scholar]
  80. Marano CM, Workman CI, Lyman CH, Munro CA, Kraut MA. et al. 2015. Structural imaging in late life depression: association with mood and cognitive responses to antidepressant treatment. Am. J. Geriatr. Psychiatry 234–12 [Google Scholar]
  81. McCaffrey R, Liehr P, Gregersen T, Nishioka R. 2011. Garden walking and art therapy for depression in older adults: a pilot study. Res. Gerontol. Nurs. 4:237–42 [Google Scholar]
  82. McClintock SM, Choi J, Deng ZD, Appelbaum LG, Krystal AD, Lisanby SH. 2014. Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J. ECT 30:165–76 [Google Scholar]
  83. Metti AL, Cauley JA, Newman AB, Ayonayon HN, Barry LC. et al. 2013. Plasma beta amyloid level and depression in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 68:74–79 [Google Scholar]
  84. Miller MD, Reynolds CF 3rd. 2007. Expanding the usefulness of Interpersonal Psychotherapy (IPT) for depressed elders with co-morbid cognitive impairment. Int. J. Geriatr. Psychiatry 22:101–5 [Google Scholar]
  85. Morimoto SS, Alexopoulos GS. 2013. Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment. Psychiatr. Clin. N. Am. 36:517–31 [Google Scholar]
  86. Mowszowski L, Hermens DF, Diamond K, Norrie L, Cockayne N. et al. 2014. Cognitive training enhances pre-attentive neurophysiological responses in older adults “at risk” of dementia. J. Alzheimers Dis. 41:41095–108 [Google Scholar]
  87. Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE. et al. 2012. Cognitive outcomes after sertraline treatment in patients with depression of Alzheimer disease. Am. J. Geriatr. Psychiatry 20:1036–44 [Google Scholar]
  88. Murrock CJ, Graor CH. 2014. The effects of dance on depression, physical function, and disability in underserved adults. J. Aging Phys. Act. 22:3380–85 [Google Scholar]
  89. Naismith SL, Diamond K, Carter PE, Norrie LM, Redoblado-Hodge MA. et al. 2011. Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program. Am. J. Geriatr. Psychiatry 19:240–48 [Google Scholar]
  90. Naismith SL, Mowszowski L, Ward PB, Diamond K, Paradise M. et al. 2012. Reduced temporal mismatch negativity in late-life depression: an event-related potential index of cognitive deficit and functional disability?. J. Affect. Disord. 138:71–78 [Google Scholar]
  91. Nash JD, Newberg A. 2013. Toward a unifying taxonomy and definition for meditation. Front. Psychol. 4:806 [Google Scholar]
  92. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V. et al. 2005. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53:695–99 [Google Scholar]
  93. Norrie LM, Diamond K, Hickie IB, Rogers NL, Fearns S. et al. 2011. Can older “at risk” adults benefit from psychoeducation targeting healthy brain aging?. Int. Psychogeriatr. 23:413–24 [Google Scholar]
  94. Obermann KR, Morris JC, Roe CM. 2013. Exploration of 100 commonly used drugs and supplements on cognition in older adults. Alzheimers Dement. 9:724–32 [Google Scholar]
  95. Odetti L, Anerdi G, Barbieri MP, Mazzei D, Rizza E. et al. 2007. Preliminary experiments on the acceptability of animaloid companion robots by older people with early dementia. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007:1816–19 [Google Scholar]
  96. Pal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML. et al. 2013. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst. Rev. 3:CD008776 [Google Scholar]
  97. Patel NK, Newstead AH, Ferrer RL. 2012. The effects of yoga on physical functioning and health related quality of life in older adults: a systematic review and meta-analysis. J. Altern. Complement. Med. 18:902–17 [Google Scholar]
  98. Pehrson AL, Sanchez C. 2014. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 19:121–33 [Google Scholar]
  99. Pelton GH, Andrews H, Roose SP, Marcus SM, D'Antonio K. et al. 2013. Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design. Contemp. Clin. Trials 37:200–8 [Google Scholar]
  100. Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N. et al. 2008. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int. J. Geriatr. Psychiatry 23:670–76 [Google Scholar]
  101. Pimontel MA, Culang-Reinlieb ME, Morimoto SS, Sneed JR. 2012. Executive dysfunction and treatment response in late-life depression. Int. J. Geriatr. Psychiatry 27:893–99 [Google Scholar]
  102. Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C. et al. 2014. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 311:682–91 [Google Scholar]
  103. Potter GG, Wagner HR, Burke JR, Plassman BL, Welsh-Bohmer KA. et al. 2013. Neuropsychological predictors of dementia in late-life major depressive disorder. Am. J. Geriatr. Psychiatry 21:297–306 [Google Scholar]
  104. Radloff LS. 1977. The CES-D Scale: a self-report depression scale for research in the general population. J. Appl. Psychol. Meas. 1:385–401 [Google Scholar]
  105. Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J. et al. 2007. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am. J. Psychiatry 164:900–9 [Google Scholar]
  106. Reinlieb M, Ercoli LM, Siddarth P, St Cyr N, Lavretsky H. 2014. The patterns of cognitive and functional impairment in amnestic and non-amnestic mild cognitive impairment in geriatric depression. Am. J. Geriatr. Psychiatry 221487–95 [Google Scholar]
  107. Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA. et al. 2011. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch. Gen. Psychiatry 68:51–60 [Google Scholar]
  108. Rogers CE, Larkey LK, Keller C. 2009. A review of clinical trials of tai chi and qigong in older adults. West. J. Nurs. Res. 31:245–79 [Google Scholar]
  109. Rosenberg D, Depp CA, Vahia IV, Reichstadt J, Palmer BW. et al. 2010. Exergames for subsyndromal depression in older adults: a pilot study of a novel intervention. Am. J. Geriatr. Psychiatry 18:221–26 [Google Scholar]
  110. Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW. et al. 2013. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J. Clin. Psychiatry 74:810–16 [Google Scholar]
  111. Rosenberg PB, Mielke MM, Han D, Leoutsakos JS, Lyketsos CG. et al. 2012. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int. J. Geriatr. Psychiatry 27:1248–57 [Google Scholar]
  112. Salloway S, Malloy P, Kohn R, Gillard E, Duffy J. et al. 1996. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 46:1567–74 [Google Scholar]
  113. Sapolsky RM. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57:925–35 [Google Scholar]
  114. Schönknecht P, Pantel J, Kaiser E, Thomann P, Schröder J. 2007. Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia. Neurosci. Lett. 416:39–42 [Google Scholar]
  115. Scogin F, Fairchild JK, Yon A, Welsh DL, Presnell A. 2014. Cognitive bibliotherapy and memory training for older adults with depressive symptoms. Aging Ment. Health 18:554–60 [Google Scholar]
  116. Semkovska M, McLoughlin DM. 2010. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol. Psychiatry 68:568–77 [Google Scholar]
  117. Sharpe L, Gittins CB, Correia HM, Meade T, Nicholas MK. et al. 2012. Problem-solving versus cognitive restructuring of medically ill seniors with depression (PROMISE-D trial): study protocol and design. BMC Psychiatry 12:207 [Google Scholar]
  118. Sheikh JI, Yesavage JA. 1986. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. . In Clinical Gerontology: A Guide to Assessment and Intervention, ed. TL Brink 165–73 New York: The Haworth Press [Google Scholar]
  119. Sheline YI, Barch DM, Garcia K, Gersing K, Pieper C. et al. 2006. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol. Psychiatry 60:58–65 [Google Scholar]
  120. Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC. et al. 2010. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch. Gen. Psychiatry 67:277–85 [Google Scholar]
  121. Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM. et al. 2008. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am. J. Psychiatry 165:524–32 [Google Scholar]
  122. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO. et al. 2014. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 71:5581–88 [Google Scholar]
  123. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM. et al. 2012. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br. J. Nutr. 107:1682–93 [Google Scholar]
  124. Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK. et al. 2013. Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 74:966–73 [Google Scholar]
  125. Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP. et al. 2010. Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression. Am. J. Geriatr. Psychiatry 18:128–35 [Google Scholar]
  126. Sosa AL, Albanese E, Stephan BC, Dewey M, Acosta D. et al. 2012. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLOS Med. 9:e1001170 [Google Scholar]
  127. Spitzer R, Kroenke K, Williams J. 1999. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. J. Am. Med. Assoc. 282:1737–44 [Google Scholar]
  128. Steenland K, Karnes C, Seals R, Carnevale C, Hermida A. et al. 2012. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J. Alzheimers Dis. 31:265–75 [Google Scholar]
  129. Steffens DC, McQuoid DR, Potter GG. 2009. Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. J. Geriatr. Psychiatry Neurol. 22:52–61 [Google Scholar]
  130. Steffens DC, Snowden M, Fan MY, Hendrie H, Katon WJ. et al. 2006. Cognitive impairment and depression outcomes in the IMPACT study. Am. J. Geriatr. Psychiatry 14:401–9 [Google Scholar]
  131. Story TJ, Potter GG, Attix DK, Welsh-Bohmer KA, Steffens DC. 2008. Neurocognitive correlates of response to treatment in late-life depression. Am. J. Geriatr. Psychiatry 16:752–59 [Google Scholar]
  132. Sullivan MD, Katon WJ, Lovato LC, Miller ME, Murray AM. et al. 2013. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 70:1041–47 [Google Scholar]
  133. Sun X, Chiu CC, Liebson E, Crivello NA, Wang L. et al. 2009. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele. Alzheimer Dis. Assoc. Disord. 23:238–44 [Google Scholar]
  134. Szanto K, Clark L, Hallquist M, Vanyukov P, Crockett M. et al. 2014. The cost of social punishment and high-lethality suicide attempts in the second half of life. Psychol. Aging 29:84–94 [Google Scholar]
  135. Szanto K, Dombrovski AY, Sahakian BJ, Mulsant BH, Houck PR. et al. 2012. Social emotion recognition, social functioning, and attempted suicide in late-life depression. Am. J. Geriatr. Psychiatry 20:257–65 [Google Scholar]
  136. Szymkowicz SM, Finnegan N, Dale RM. 2014. Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder. J. Clin. Psychopharmacol. 34:285–86 [Google Scholar]
  137. Tadayonnejad R, Ajilore O. 2014. Brain network dysfunction in late-life depression: a literature review. J. Geriatr. Psychiatry Neurol. 27:5–12 [Google Scholar]
  138. Taylor WD, Aizenstein HJ, Alexopoulos GS. 2013. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol. Psychiatry 18:963–74 [Google Scholar]
  139. Taylor WD, McQuoid DR, Payne ME, Zannas AS, Macfall JR, Steffens DC. 2014. Hippocampus atrophy and the longitudinal course of late-life depression. Am. J. Geriatr. Psychiatry 221504–12 [Google Scholar]
  140. Telles S, Singh N. 2013. Science of the mind: ancient yoga texts and modern studies. Psychiatr. Clin. N. Am. 36:93–108 [Google Scholar]
  141. Thompson DG, Kesler SR, Sudheimer K, Mehta KM, Thompson LW. et al. 2015. fMRI activation during executive function predicts response to cognitive behavioral therapy in older, depressed adults. Am. J. Geriatr. Psychiatry 2313–22 [Google Scholar]
  142. Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I. et al. 2012. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms—the Beyond Ageing Project: a randomized controlled trial. Am. J. Clin. Nutr. 95:194–203 [Google Scholar]
  143. Wesnes K, Bose A, Gommoll C, Chen C. 2013. Effects of levomilnacipran SR on measures of attention in a phase 3 trial of major depressive disorder (MDD). Presented at NCDEU 53rd Meet., Am. Soc. Clin. Psychopharmacol., Hollywood, CA [Google Scholar]
  144. Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L. et al. 2013. Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry 70:1320–28 [Google Scholar]
  145. Xie C, Li W, Chen G, Douglas Ward B, Franczak MB. et al. 2012. The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study. Behav. Brain Res. 235:244–50 [Google Scholar]
  146. Yeh YC, Tsang HY, Lin PY, Kuo YT, Yen CF. et al. 2011. Subtypes of mild cognitive impairment among the elderly with major depressive disorder in remission. Am. J. Geriatr. Psychiatry 19:923–31 [Google Scholar]
  147. Zahodne LB, Gongvatana A, Cohen RA, Ott BR, Tremont G. 2013. Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment?. Am. J. Geriatr. Psychiatry 21:1098–106 [Google Scholar]
  148. Zarate CA Jr, Singh JB, Quiroz JA, De Jesus G, Denicoff KK. et al. 2006. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am. J. Psychiatry 163:153–55 [Google Scholar]
/content/journals/10.1146/annurev-clinpsy-032814-112828
Loading
/content/journals/10.1146/annurev-clinpsy-032814-112828
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error